v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities    
Net loss $ (11,417) $ (21,952)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 356 544
Stock-based compensation 14,762 17,091
Accretion of investments (236) (725)
Other 663 122
Changes in operating assets and liabilities:    
Accounts receivable, net 1,774 9,807
Prepaid expenses and other assets (876) (3,640)
Operating lease right-of-use assets 760 694
Accounts payable (1,874) 784
Operating lease liabilities (2,258) (2,029)
Accrued expenses and other liabilities (407) (328)
Net cash provided by operating activities 1,247 368
Cash flows from investing activities    
Purchases of property and equipment (70) (28)
Purchases of marketable securities (57,925) (79,381)
Sales of marketable securities 35,667 62,454
Maturities of marketable securities 45,040 38,506
Net cash provided by investing activities 22,712 21,551
Cash flows from financing activities    
Proceeds from issuance of common stock upon exercise of stock options 1,081 1,591
Proceeds from issuance of common stock under employee stock purchase plan 418 713
Tax withholdings on restricted stock units (4,767) (6,019)
Repurchase of common stock (28,659) (9,130)
Net cash used in financing activities (31,927) (12,845)
Effect of exchange rate changes on cash and cash equivalents (63) 3
Net increase (decrease) in cash, cash equivalents, and restricted cash (8,031) 9,077
Cash, cash equivalents, and restricted cash at beginning of period 71,720 56,721
Cash, cash equivalents, and restricted cash at end of period 63,689 65,798
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets    
Cash and cash equivalents 56,148 57,338
Restricted cash, non-current 7,541 8,460
Total cash, cash equivalents, and restricted cash $ 63,689 $ 65,798